title: Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
abstract: Both our previous and the present studies established that increases in cyclic guanosine monophosphate (cGMP) reflect the activity of atrial natriuretic factor (ANF). The ANF message is transmitted by particulate guanylate cyclase, which appears to be in intimate contact with the ANF receptor since stimulation of particulate guanylate cyclase is observed even after dispersion of the membranes. The stimulation of smooth muscle and endothelial cells in culture leads to egression of cGMP to extracellular medium where it accumulates for over 2 h. The signal of the extracellular cGMP is magnified and prolonged compared to the intracellular signal. The stimulation of cGMP production by ANF in vascular smooth muscle and endothelial cells appears to be relatively irreversible and the responsiveness is down-regulated by prior exposure to low doses of ANF. Cyclic guanosine monophosphate can also serve as a marker for ANF action. Atrial natriuretic factor fragments of different potencies exert a biological activity that correlates with ANF-induced cGMP increases. In hypertensive rats and monkeys, where acute infusion of ANF leads to an exaggerated diuresis and natriuresis, urinary cGMP does not appear to be different. Overall, cGMP appears to be a mediator and a marker of ANF biological activity and may serve as a useful tool in the study of pathogenesis of hypertension.
authors.forename: P
authors.initials: P
authors.lastname: Hamet
authors.forename: J
authors.initials: J
authors.lastname: Tremblay
authors.forename: S C
authors.initials: SC
authors.lastname: Pang
authors.forename: R
authors.initials: R
authors.lastname: Skuherska
authors.forename: E L
authors.initials: EL
authors.lastname: Schiffrin
authors.forename: R
authors.initials: R
authors.lastname: Garcia
authors.forename: M
authors.initials: M
authors.lastname: Cantin
authors.forename: J
authors.initials: J
authors.lastname: Genest
authors.forename: R
authors.initials: R
authors.lastname: Palmour
authors.forename: F R
authors.initials: FR
authors.lastname: Ervin
mesh_terms: D000818:Animals; D009320:Atrial Natriuretic Factor / Q000494:pharmacology* / Q000627:therapeutic use; D002417:Cattle; D002522:Chlorocebus aethiops; D006152:Cyclic GMP / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D006162:Guanylate Cyclase / Q000378:metabolism; D006973:Hypertension / Q000188:drug therapy; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology; D010974:Platelet Aggregation / Q000187:drug effects; D051381:Rats
chemical_list: D009320:Atrial Natriuretic Factor; D006162:Guanylate Cyclase; D006152:Cyclic GMP